tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IMRX Stock Latest News

Immuneering files to sell 9.18M shares of Class A common stock for holders
The FlyImmuneering files to sell 9.18M shares of Class A common stock for holders
18h ago
IMRX
Immuneering’s Strategic Partnerships and Promising Clinical Developments Justify Buy Rating
PremiumRatings
Immuneering’s Strategic Partnerships and Promising Clinical Developments Justify Buy Rating
9d ago
IMRX
Immuneering announces clinical supply agreement with Eli Lilly
PremiumThe Fly
Immuneering announces clinical supply agreement with Eli Lilly
10d ago
LLY
IMRX
Immuneering prices 6.3M shares at $3.95 in private placement
PremiumThe Fly
Immuneering prices 6.3M shares at $3.95 in private placement
14d ago
IMRX
Immuneering Corp. Reports Strong Trial Results and Patent Win
PremiumCompany Announcements
Immuneering Corp. Reports Strong Trial Results and Patent Win
21d ago
IMRX
Immuneering files $300M mixed securities shelf
PremiumThe FlyImmuneering files $300M mixed securities shelf
21d ago
IMRX
Immuneering reports Q2 EPS (40c), consensus (40c)
Premium
The Fly
Immuneering reports Q2 EPS (40c), consensus (40c)
21d ago
IMRX
Immuneering granted atebimetinib patent by USPTO
Premium
The Fly
Immuneering granted atebimetinib patent by USPTO
2M ago
IMRX
Immuneering price target raised to $10 from $8 at Mizuho
PremiumThe Fly
Immuneering price target raised to $10 from $8 at Mizuho
3M ago
IMRX
Immuneering’s Promising Clinical Developments and Future Prospects Justify Buy Rating
PremiumRatings
Immuneering’s Promising Clinical Developments and Future Prospects Justify Buy Rating
3M ago
IMRX
Morning Movers: Verve skyrockets after deal to be acquired by Eli Lilly
PremiumThe Fly
Morning Movers: Verve skyrockets after deal to be acquired by Eli Lilly
3M ago
DYN
JBL
Immuneering Announces Promising Phase 2a Trial Results
PremiumCompany Announcements
Immuneering Announces Promising Phase 2a Trial Results
3M ago
8K
IMRX
Immuneering’s atebimetinibin shows positive survival data in pancreatic cancer
PremiumThe FlyImmuneering’s atebimetinibin shows positive survival data in pancreatic cancer
3M ago
IMRX
Immuneering Elects New Directors at Annual Meeting
Premium
Company Announcements
Immuneering Elects New Directors at Annual Meeting
3M ago
8K
IMRX
Positive Buy Rating for Immuneering Driven by Promising Clinical Data and Competitive Positioning
Premium
Ratings
Positive Buy Rating for Immuneering Driven by Promising Clinical Data and Competitive Positioning
3M ago
IMRX
Immuneering price target lowered to $21 from $25 at Oppenheimer
PremiumThe Fly
Immuneering price target lowered to $21 from $25 at Oppenheimer
4M ago
IMRX
Positive Outlook for Immuneering: Buy Rating Backed by Strategic Developments and Promising Clinical Data
PremiumRatings
Positive Outlook for Immuneering: Buy Rating Backed by Strategic Developments and Promising Clinical Data
4M ago
IMRX
Immuneering Corp. Reports Promising Q1 2025 Results
PremiumCompany Announcements
Immuneering Corp. Reports Promising Q1 2025 Results
4M ago
IMRX
Immuneering reports Q1 EPS (42c), consensus (58c)
PremiumThe Fly
Immuneering reports Q1 EPS (42c), consensus (58c)
4M ago
IMRX
Immuneering’s Promising Potential: Buy Rating Backed by Strategic Expansion and Data Generation
PremiumRatingsImmuneering’s Promising Potential: Buy Rating Backed by Strategic Expansion and Data Generation
5M ago
IMRX
Immuneering Corp. Reports Promising Cancer Trial Results
Premium
Company Announcements
Immuneering Corp. Reports Promising Cancer Trial Results
6M ago
IMRX
Immuneering management to meet with Oppenheimer
Premium
The Fly
Immuneering management to meet with Oppenheimer
6M ago
IMRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >